Published by The Medical Letter, Inc. • 145 Huguenot Street, Suite 312, New Rochelle, N.Y. 10801 • A Nonprofit Publication

   options

 

Select a year:   
TABLE OF CONTENTS
2010 issues - volume 8 • Treatment Guidelines Accessing & Pricing  
 
September, 2010 (Issue 97)   Subscriber Download: Full Text or PDF  
Treatment of Atrial Fibrillation  p.65  
The treatment of atrial fibrillation includes ventricular rate control, anticoagulation, conversion to normal sinus rhythm and maintenance of sinus rhythm. The choice of therapies that can achieve these goals is discussed in the text that follows. Some drugs are recommended here for indications that have not been approved by the FDA.
August, 2010 (Issue 96)   Subscriber Download: Full Text or PDF   top
Drugs for Psychotic Disorders  p.61  
The antipsychotic drugs listed in Table 1 on the next page are more effective for treating the "positive symptoms" of schizophrenia (hallucinations and delusions) than the "negative symptoms" (apathy, social withdrawal, and blunted affect). Some symptoms of schizophrenia and acute psychoses may improve rapidly after treatment with antipsychotic drugs, but chronic schizophrenia improves slowly over many weeks and some patients may continue to improve for months. Most patients with chronic schizophrenia require prolonged maintenance therapy, but the risk of tardive dyskinesia and adverse metabolic effects must be kept in mind.
July, 2010 (Issue 95)   Subscriber Download: Full Text or PDF  
Drugs for Sexually Transmitted Infections  p.53  
Many infections can be transmitted during sexual contact. The text and tables that follow are limited to management of sexually transmitted infections (STIs) other than HIV, viral hepatitis and enteric infections. The drugs of choice, their dosages and alternatives are listed in Table 1. Table 2 lists the adverse effects of some of these antimicrobials.
Drugs for Parasitic Infections  p.1  
With increasing travel, immigration, use of immunosuppressive drugs and the spread of AIDS, physicians anywhere may see infections caused by parasites. The table below lists first-choice and alternative drugs for most parasitic infections. The table on page 12 summarizes the known prenatal risks of antiparasitic drugs. The brand names and manufacturers of the drugs are listed on page 14.
June, 2010 (Issue 94)   Subscriber Download: Full Text or PDF   top
Drugs for Bacterial Infections  p.43  
The article reviews some common bacterial infections and their treatment. The recommendations made here are based on the results of susceptibility studies, clinical trials and the opinions of Medical Letter consultants.
May, 2010 (Issue 93)   Subscriber Download: Full Text or PDF  
Drugs for Depression and Bipolar Disorder  p.35  
Drugs are not the only treatment for mood disorders. Psychotherapy remains an important component in the management of these disorders, and electroconvulsive therapy (ECT) has a long history of efficacy and safety when drugs are ineffective, poorly tolerated or cannot be used. Some drugs are recommended here for indications that have not been approved by the FDA.
April, 2010 (Issue 92)   Subscriber Download: Full Text or PDF   top
Drugs for Pain  p.25  
Pain can be acute or chronic. Chronic pain has been broadly classified into two types: nociceptive and neuropathic. Nociceptive pain can be treated with nonopioid analgesics or opioids. Neuropathic pain is less responsive to opioids; adjuvant medicines such as antidepressants and anticonvulsants are often used to treat neuropathic pain. Combining different types of analgesics may provide an additive analgesic effect without increasing adverse effects.
March, 2010 (Issue 91)   Subscriber Download: Full Text or PDF  
Drugs for Cognitive Loss and Dementia  p.19  
Alzheimer’s disease (AD) is the most common form of dementia, but cognitive loss is also associated with other neurological conditions such as Parkinson’s disease, dementia with Lewy bodies or vascular dementia.
February, 2010 (Issue 90)   Subscriber Download: Full Text or PDF   top
Drugs for Allergic Disorders  p.9  
Allergic rhinitis, allergic conjunctivitis, atopic dermatitis, urticaria, anaphylaxis and asthma (not included here; reviewed in Treatment Guidelines 2008; 6:83) are prevalent worldwide, especially in industrialized countries. Pharmacologic treatment of these disorders continues to improve in efficacy and safety. In addition to using drugs to prevent and control these allergic diseases, patients should be instructed to avoid, if possible, specific allergens and/or environmental conditions that trigger or worsen their symptoms. Allergen-specific immunotherapy may be useful for treatment of allergic rhinitis and allergic conjunctivitis, and in preventing severe insect venomtriggered reactions.
January, 2010 (Issue 89)   Subscriber Download: Full Text or PDF  
Drugs for Some Common Eye Disorders  p.1  
Drugs for glaucoma, age-related macular degeneration, bacterial conjunctivitis, and dry eyes are reviewed here. Ophthalmic drugs can have local and systemic adverse effects. In addition, for some elderly patients, the complexity of self-administering numerous ophthalmic drugs may be the limiting factor in their ability to care for themselves. Drugs for the treatment of allergic conjunctivitis will be reviewed in a future issue of Treatment Guidelines on Drugs for Allergic Disorders.
Article Accessing and Pricing
  FREE to everyone
  FREE to subscribers
Issue is available online to The Medical Letter subscribers signed up for online privileges.
 Issue is free to institutional users.
  $12.00
Non-subscribers may order copies of this issue of The Medical Letter and receive by postal mail or electronic download.
  $10.00
Non-subscribers may purchase online by credit card on our secure server and download this The Medical Letter article.
  FREE to everyone
  FREE to subscribers
Issue is available online to Treatment Guidelines subscribers signed up for online privileges.
 Issue is free to institutional users.
  $12.00
Non-subscribers may order copies of this issue of Treatment Guidelines and receive by postal mail or electronic download.
WANT TO SUBSCRIBE?
Subscribing online to The Medical Letter or Treatment Guidelines gives you the following privileges:
Access to the current issue of The Medical Letter or Treatment Guidelines (two separate subscriptions) on the day it is published.
Access to all articles published by The Medical Letter since 1988 or to Treatment Guidelines since its inception (September 2002).
As a subscriber to The Medical Letter or Treatment Guidelines, you will also receive your copy of the current issue by postal mail.
   
Individual Subscriptions - Individual print and online access, including access to a limited section of the searchable archives.  Shared access not allowed.
Individual Librarian Subscriptions - Print and online access for the head librarian only. It allows the librarian to conduct searches and provide data. Shared access not allowed
Group Site License - Preview Site License.  Print and online access for multiple users at multiple locations including access to the entire searchable archives. Please e-mail us for further information regarding The Medical Letter's pricing platform for site licenses.
 
 
 

 

 

 

 

 

 

 

© 2010 The Medical Letter. All rights reserved. Use of this site signifies your agreement to the Terms and Conditions.